Galy

GALY is a Boston, Massachusetts-based deep tech and climate tech company that applies cellular agriculture and biomanufacturing to produce agricultural commodities from plant cells rather than conventional field cultivation. The company describes its approach as "biocrafting": growing raw materials in controlled environments so that outputs retain the attributes of the plant-derived original while offering traceability, customization and reduced resource use across energy, water and land. Its flagship product is GALY Cotton, an in-vitro cotton produced from cotton cells, developed with the aim of scaling in-vitro cotton production to industrial volumes, an approach the company states has not previously been done at that scale.

Since the Series B, GALY has extended its platform beyond cotton to additional plant cell-based products, most prominently cocoa, which it markets to chocolate makers and other specialty producers. The company's stated positioning is climate adaptation: management argues that extreme weather is increasing volatility in conventional agricultural supply chains, citing rising cocoa prices, and that controlled-environment production can provide predictable, year-round supply and onshore production capacity.

The team spans genetic engineering, plant cell culture, bioreactor development, mathematics and statistics, automation, design and branding. Reported headcount ranges from 21-50 to 51-100 employees depending on the directory source.

Founding story

GALY was founded in 2019 by Luciano Bueno, who framed the company around the question of whether the world's most essential products could be grown rather than extracted. Starting with a small team and limited resources, the company built early prototypes of biocrafted products and set out to rethink how industries source cocoa and cotton. Boston Startup Hub also lists Paula Elbl as a co-founder.

Business model

GALY operates a business-to-business model, developing biocrafted ingredients and materials — cotton fiber and cocoa — that are supplied to brand partners across textiles, apparel, food and medical products. The company emphasizes partnerships with brands and long-term sourcing arrangements, having signed its first long-term sourcing agreement in 2023, and works with corporate partners and investors such as H&M Group, Inditex and Suzuran Medical.

Revenue is oriented toward the sale and supply of biocrafted raw materials and ingredients to brand partners, including through long-term sourcing agreements; the company also positions its platform for customized production tailored to client specifications.

Traction

Milestones reported by the company include opening its first owned lab inside a shipping container in 2020, achieving the first proof of concept for GALY Cotton in 2021, relocating from Western Massachusetts to Boston and scaling into large tanks in 2022, signing its first long-term sourcing agreement and introducing the first fabric made with GALY Cotton in 2023, and expanding the platform to multiple new products in 2024. The company reports raising over $60 million to date and a partnership with Suzuran Medical cited by Forbes in 2023.

Latest developments

In May 2026 GALY was honored at the Edison Awards for its approaches to cocoa and cotton production, after being named a finalist. The company continues to commercialize both biocrafted cotton and cocoa product lines following its 2024 Series B.